13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001762304
Total reported value
$832.1M
$832.1M
36 檔
256.4%
According to the latest 13F quarterly dataset, Hhlr Advisors, LTD. managed an equity portfolio of $832.1M at the end of Q2 2025, spanning 36 distinct U.S. exchange-listed positions.
In Q2 2025, Hhlr Advisors, LTD. adopted a defensive or profit-taking posture, trimming 9 positions and completely liquidating 15 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PDD | Pdd Holdings Inc | Stock-Consumer Disc | 23.52% | -20.86% | +6.31% | |
| 2 | FUTU | Futu Holdings Ltd-adr | Stock-Financials | 17.17% | +8.32% | +0.11% | |
| 3 | ✓ | Stock-Other | 12.74% | -0.19% | — | ||
| 4 | ONC | Beone Medicines Ltd-adr | Stock-Other | 8.06% | -18.36% | EXIT | |
| 5 | NTES | Netease Inc-adr | Stock-Comm Services | 7.21% | +0.54% | NEW | |
| 6 | LEGN | Legend Biotech Corp-adr | Stock-Other | 6.84% | +14.30% | — | |
| 7 | BEKE | Ke Holdings Inc-adr | Stock-Other | 4.27% | +0.08% | -37.65% | |
| 8 | BABA | Alibaba Group Holding-sp Adr | Stock-Consumer Disc | 4.20% | -16.28% | -70.58% | |
| 9 | AVBP | Arrivent Biopharma Inc | Stock-Other | 3.14% | +10.98% | — | |
| 10 | ✓ | Wns Holdings LTD | Stock-Other | 3.12% | — | — | |
| 11 | JD | Jd.com Inc-adr | Stock-Consumer Disc | 2.39% | — | -52.71% | |
| 12 | YSG | Yatsen Holding Ltd-adr | Stock-Other | 1.90% | +0.96% | -11.24% | |
| 13 | CWAN | Clearwater Analytics Holdings, Inc. | Stock-Tech | 0.96% | -1.93% | EXIT | |
| 14 | CTKB | Cytek Biosciences Inc | Stock-Other | 0.73% | +1.80% | — | |
| 15 | VIPS | Vipshop Holdings LTD - Adr | Stock-Consumer Disc | 0.55% | +5.41% | -83.07% | |
| 16 | LI | Li Auto Inc - Adr | Stock-Other | 0.54% | — | — | |
| 17 | NBP | Novabridge Biosciences | Stock-Other | 0.47% | +0.52% | — | |
| 18 | ZTO | Zto Express Cayman Inc-adr | Stock-Other | 0.38% | — | — | |
| 19 | BZ | Kanzhun LTD - Adr | Stock-Other | 0.33% | — | — | |
| 20 | API | Agora Inc-adr | Stock-Other | 0.26% | +0.57% | — | |
| 21 | GOSS | Gossamer Bio Inc | Stock-Other | 0.20% | — | — | |
| 22 | MAZE | Maze Therapeutics Inc | Stock-Other | 0.18% | +0.66% | — | |
| 23 | SGMT | Sagimet Biosciences Inc-a | Stock-Other | 0.18% | +0.44% | — | |
| 24 | EM | Smart Share Global LTD - Adr | Stock-Other | 0.15% | — | — | |
| 25 | TUYA | Tuya Inc | Stock-Other | 0.12% | +0.11% | — | |
| 26 | CTNM | Contineum Therapeutics Inc-a | Stock-Other | 0.09% | +0.80% | — | |
| 27 | MOGU | Mogu Inc-adr | Stock-Other | 0.06% | +0.06% | — | |
| 28 | BEDU | Bright Scholar Education-adr | Stock-Other | 0.06% | — | — | |
| 29 | GE | General Electric | Stock-Industrials | 0.05% | +0.28% | -6.69% | |
| 30 | MCO | Moody's CORP | Stock-Financials | 0.04% | — | -6.11% | |
| 31 | MSCI | Msci Inc | Stock-Financials | 0.04% | — | -5.64% | |
| 32 | PACB | Pacific Biosciences Of Calif | Stock-Other | 0.04% | +0.12% | — | |
| 33 | ALGS | Aligos Therapeutics Inc | Stock-Other | 0.02% | +0.02% | — | |
| 34 | ✓ | Stock-Other | — | — | — | ||
| 35 | UXIN | Uxin LTD - Adr | Stock-Other | — | — | EXIT | |
| 36 | ✓ | Stock-Other | — | — | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | +12.7% | NEW | New buy | |
| 2 | FUTU | Futu Holdings Ltd-adr | +4.7% | +0.11% | Add |
| 3 | PDD | Pdd Holdings Inc | +1.6% | +6.31% | Add |
| 4 | LEGN | Legend Biotech Corp-adr | +1.1% | — | Unchanged |
| 5 | CWAN | Clearwater Analytics Holdings, Inc. | +1% | NEW | New buy |
| 6 | YSG | Yatsen Holding Ltd-adr | +1% | -11.24% | Trim |
| 7 | AVBP | Arrivent Biopharma Inc | +0.8% | — | Unchanged |
| 8 | ✓ | Wns Holdings LTD | +0.5% | — | Unchanged |
| 9 | NBP | Novabridge Biosciences | +0.3% | — | Unchanged |
| 10 | ONC | Beone Medicines Ltd-adr | +0.1% | — | Unchanged |
| 11 | SGMT | Sagimet Biosciences Inc-a | +0.1% | — | Unchanged |
| 12 | LI | Li Auto Inc - Adr | +0.1% | — | Unchanged |
| 13 | GOSS | Gossamer Bio Inc | +0.1% | — | Unchanged |
| 14 | MAZE | Maze Therapeutics Inc | 0% | — | Unchanged |
| 15 | BZ | Kanzhun LTD - Adr | 0% | — | Unchanged |
| 16 | API | Agora Inc-adr | 0% | — | Unchanged |
| 17 | EM | Smart Share Global LTD - Adr | 0% | — | Unchanged |
| 18 | GE | General Electric | 0% | -6.69% | Trim |
| 19 | BEDU | Bright Scholar Education-adr | 0% | — | Unchanged |
| 20 | MOGU | Mogu Inc-adr | 0% | — | Unchanged |
| 21 | PACB | Pacific Biosciences Of Calif | 0% | — | Unchanged |
| 22 | MSCI | Msci Inc | 0% | -5.64% | Trim |
| 23 | MCO | Moody's CORP | 0% | -6.11% | Trim |
| 24 | ZTO | Zto Express Cayman Inc-adr | — | — | Unchanged |
| 25 | ALGS | Aligos Therapeutics Inc | — | — | Unchanged |
| 26 | UXIN | Uxin LTD - Adr | — | — | Unchanged |
| 27 | ✓ | — | — | Unchanged | |
| 28 | TUYA | Tuya Inc | 0% | — | Unchanged |
| 29 | ✓ | Ecarx Holdings Inc | 0% | EXIT | Sold out |
| 30 | MGX | Metagenomi Therapeutics Inc | 0% | EXIT | Sold out |
| 31 | ✓ | 0% | — | Unchanged | |
| 32 | CTKB | Cytek Biosciences Inc | 0% | — | Unchanged |
| 33 | XYF | X Financial-adr | 0% | EXIT | Sold out |
| 34 | CYD | China Yuchai International Limited | 0% | EXIT | Sold out |
| 35 | WB | Weibo Corp-spon Adr | 0% | EXIT | Sold out |
| 36 | CTNM | Contineum Therapeutics Inc-a | 0% | — | Unchanged |
| 37 | JOYY | Joyy Inc-adr | 0% | EXIT | Sold out |
| 38 | DHR | Danaher CORP | -0.1% | EXIT | Sold out |
| 39 | SOHU | Sohu.com Ltd-adr | -0.1% | EXIT | Sold out |
| 40 | TSM | Taiwan Semiconductor-sp Adr | -0.2% | EXIT | Sold out |
| 41 | ATAT | Atour Lifestyle Holdings-adr | -0.2% | EXIT | Sold out |
| 42 | HTHT | H World Group Ltd-adr | -0.3% | EXIT | Sold out |
| 43 | YUMC | Yum China Holdings Inc | -0.4% | EXIT | Sold out |
| 44 | BIDU | Baidu Inc - Spon Adr | -0.4% | EXIT | Sold out |
| 45 | NTES | Netease Inc-adr | -0.6% | -37.66% | Trim |
| 46 | ✓ | Enfusion Inc - Class A | -1.6% | EXIT | Sold out |
| 47 | TCOM | Trip.com Group Ltd-adr | -1.7% | EXIT | Sold out |
| 48 | VIPS | Vipshop Holdings LTD - Adr | -2.4% | -83.07% | Trim |
| 49 | BEKE | Ke Holdings Inc-adr | -2.5% | -37.65% | Trim |
| 50 | JD | Jd.com Inc-adr | -3.2% | -52.71% | Trim |
According to official SEC Form 13F filings, Hhlr Advisors, LTD. reported a total U.S. public equity portfolio value of $832.1M across 36 disclosed positions in Q2 2025.
During Q2 2025, Hhlr Advisors, LTD.'s top holdings by market value included PDD (23.5%)、FUTU (17.2%)、 (12.7%). The largest single position, PDD, represented 23.5% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including PDD, FUTU, ) accounted for 256.4% of total reported equity market value during Q2 2025.
Top New Position Initiated
市值: $395.6M
Top Position Liquidated / Trimmed
TCOM
前期市值: $59.7M
In Q2 2025, Hhlr Advisors, LTD. made 28 total portfolio adjustments, initiating 2 new buys, adding to 2 positions, trimming 9 holdings, and fully liquidating 15 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.